tirzepatide and sleeplessness Does Zepbound Cause Insomnia? Tirzepatide insomnia: what causes sleep

Comparative safety data shows acute kidney injury was listed in 0.47% of tirzepatide adverse event reports versus 1.07% of semaglutide reports in the FDA Adverse Event Reporting System (FAERS), with the reporting odds ratio favoring tirzepatide

In the 12mg cohort, 83% of participants achieved at least 15% weight loss, and more than half exceeded 25%

In a clinical trial, participants who took oral Wegovy lost 13.6% of their total body weight on average over about 15 months, compared with a 2.2% loss if they took a placebo, or dummy pill

And, above all, the genetic effects detected are small. What are the implications, and how does this fit with existing evidence